BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8652511)

  • 1. Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization.
    Zhao Y; Ke H
    Biochemistry; 1996 Jun; 35(23):7356-61. PubMed ID: 8652511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic implication of crystal structures of the cyclophilin-dipeptide complexes.
    Zhao Y; Ke H
    Biochemistry; 1996 Jun; 35(23):7362-8. PubMed ID: 8652512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy.
    Kallen J; Spitzfaden C; Zurini MG; Wider G; Widmer H; Wüthrich K; Walkinshaw MD
    Nature; 1991 Sep; 353(6341):276-9. PubMed ID: 1896075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization.
    Ke H; Mayrose D; Cao W
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3324-8. PubMed ID: 8475075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of cytoplasmic Escherichia coli peptidyl-prolyl isomerase: evidence for decreased mobility of loops upon complexation.
    Edwards KJ; Ollis DL; Dixon NE
    J Mol Biol; 1997 Aug; 271(2):258-65. PubMed ID: 9268657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamics of cyclophilin catalyzed peptidyl-prolyl isomerization by NMR spectroscopy.
    Videen JS; Stamnes MA; Hsu VL; Goodman M
    Biopolymers; 1994 Feb; 34(2):171-5. PubMed ID: 8142586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity.
    Zhao Y; Chen Y; Schutkowski M; Fischer G; Ke H
    Structure; 1997 Jan; 5(1):139-46. PubMed ID: 9016720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptidyl-prolyl cis-trans isomerase of Bacillus subtilis: identification of residues involved in cyclosporin A affinity and catalytic efficiency.
    Göthel SF; Herrler M; Marahiel MA
    Biochemistry; 1996 Mar; 35(11):3636-40. PubMed ID: 8639516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
    Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
    Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
    Fischer G; Wittmann-Liebold B; Lang K; Kiefhaber T; Schmid FX
    Nature; 1989 Feb; 337(6206):476-8. PubMed ID: 2492638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chaperonin cycle cannot substitute for prolyl isomerase activity, but GroEL alone promotes productive folding of a cyclophilin-sensitive substrate to a cyclophilin-resistant form.
    von Ahsen O; Tropschug M; Pfanner N; Rassow J
    EMBO J; 1997 Aug; 16(15):4568-78. PubMed ID: 9303301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
    Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
    J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-ray structure of a monomeric cyclophilin A-cyclosporin A crystal complex at 2.1 A resolution.
    Mikol V; Kallen J; Pflügl G; Walkinshaw MD
    J Mol Biol; 1993 Dec; 234(4):1119-30. PubMed ID: 8263916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The X-ray structure of a tetrapeptide bound to the active site of human cyclophilin A.
    Kallen J; Walkinshaw MD
    FEBS Lett; 1992 Apr; 300(3):286-90. PubMed ID: 1555657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli cyclophilin B binds a highly distorted form of trans-prolyl peptide isomer.
    Konno M; Sano Y; Okudaira K; Kawaguchi Y; Yamagishi-Ohmori Y; Fushinobu S; Matsuzawa H
    Eur J Biochem; 2004 Sep; 271(18):3794-803. PubMed ID: 15355356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific interaction between cyclophilin and cyclic peptides.
    Gallo P; Saviano M; Rossi F; Pavone V; Pedone C; Ragone R; Stiuso P; Colonna G
    Biopolymers; 1995 Sep; 36(3):273-81. PubMed ID: 7669915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin.
    Hur S; Bruice TC
    J Am Chem Soc; 2002 Jun; 124(25):7303-13. PubMed ID: 12071739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.
    Takahashi N; Hayano T; Suzuki M
    Nature; 1989 Feb; 337(6206):473-5. PubMed ID: 2644542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities.
    Rinfret A; Collins C; Ménard R; Anderson SK
    Biochemistry; 1994 Feb; 33(7):1668-73. PubMed ID: 7906541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.